CNY 9.38
(-1.99%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 1.05 Billion CNY | -37.29% |
2022 | 1.67 Billion CNY | -6.39% |
2021 | 1.79 Billion CNY | 76.62% |
2020 | 1.01 Billion CNY | 1564.06% |
2019 | 60.92 Million CNY | 44.23% |
2018 | 42.24 Million CNY | -23.76% |
2017 | 55.41 Million CNY | 9.56% |
2016 | 50.57 Million CNY | -12.81% |
2015 | 58 Million CNY | 0.31% |
2014 | 57.82 Million CNY | -0.68% |
2013 | 58.21 Million CNY | -0.29% |
2012 | 58.38 Million CNY | 5.21% |
2011 | 55.49 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 105.93 Million CNY | -28.41% |
2024 Q1 | 147.98 Million CNY | -66.55% |
2024 Q3 | 138.24 Million CNY | 30.5% |
2023 Q4 | 442.34 Million CNY | 160.96% |
2023 Q3 | 169.5 Million CNY | -15.27% |
2023 Q2 | 200.05 Million CNY | -16.41% |
2023 FY | 1.05 Billion CNY | -37.29% |
2023 Q1 | 239.34 Million CNY | -60.52% |
2022 FY | 1.67 Billion CNY | -6.39% |
2022 Q1 | 503.86 Million CNY | -36.36% |
2022 Q4 | 606.23 Million CNY | 8.96% |
2022 Q3 | 556.39 Million CNY | 11.83% |
2022 Q2 | 497.52 Million CNY | -1.26% |
2021 Q4 | 791.78 Million CNY | 73.46% |
2021 Q1 | 214.34 Million CNY | -78.21% |
2021 FY | 1.79 Billion CNY | 76.62% |
2021 Q2 | 328.11 Million CNY | 53.08% |
2021 Q3 | 456.46 Million CNY | 39.12% |
2020 Q3 | 15.18 Million CNY | 50.13% |
2020 Q1 | 4.98 Million CNY | 340.82% |
2020 FY | 1.01 Billion CNY | 1564.06% |
2020 Q4 | 983.59 Million CNY | 6377.49% |
2020 Q2 | 10.11 Million CNY | 102.87% |
2019 Q1 | 8.44 Million CNY | 6.01% |
2019 Q4 | -2.07 Million CNY | -116.35% |
2019 FY | 60.92 Million CNY | 44.23% |
2019 Q3 | 12.66 Million CNY | -17.51% |
2019 Q2 | 15.34 Million CNY | 81.65% |
2018 Q3 | 9.16 Million CNY | -43.75% |
2018 Q4 | 7.97 Million CNY | -13.04% |
2018 FY | 42.24 Million CNY | -23.76% |
2018 Q1 | 8.81 Million CNY | -20.96% |
2018 Q2 | 16.29 Million CNY | 84.81% |
2017 Q1 | 12.52 Million CNY | -6.17% |
2017 FY | 55.41 Million CNY | 9.56% |
2017 Q4 | 11.15 Million CNY | -20.47% |
2017 Q3 | 14.02 Million CNY | -20.79% |
2017 Q2 | 17.7 Million CNY | 41.35% |
2016 Q2 | 12.79 Million CNY | 5.2% |
2016 Q3 | 12.26 Million CNY | -4.21% |
2016 Q4 | 13.34 Million CNY | 8.89% |
2016 FY | 50.57 Million CNY | -12.81% |
2016 Q1 | 12.16 Million CNY | -24.98% |
2015 Q4 | 16.21 Million CNY | 6.93% |
2015 Q2 | 14.6 Million CNY | 21.63% |
2015 Q1 | 12.01 Million CNY | -41.8% |
2015 FY | 58 Million CNY | 0.31% |
2015 Q3 | 15.16 Million CNY | 3.82% |
2014 FY | 57.82 Million CNY | -0.68% |
2014 Q4 | 20.63 Million CNY | 51.68% |
2014 Q1 | 10.35 Million CNY | 0.0% |
2014 Q3 | 13.6 Million CNY | 2.88% |
2014 Q2 | 13.22 Million CNY | 27.69% |
2013 FY | 58.21 Million CNY | -0.29% |
2012 FY | 58.38 Million CNY | 5.21% |
2011 FY | 55.49 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Cachet Pharmaceutical Co., Ltd. | 733.77 Million CNY | -43.265% |
Yixintang Pharmaceutical Group Co., Ltd. | 786.44 Million CNY | -33.671% |
Luyan Pharma Co.,Ltd. | 468.55 Million CNY | -124.359% |
Ji Yao Holding Group Co., Ltd. | -346.79 Million CNY | 403.135% |